Landiolol for refractory tachyarrhythmias in the intensive care unit: case reports

Tachyarrhythmias are common complications of critically ill patients treated on intensive care units. Landiolol is an ultra-short acting beta-blocker with a very high beta1-selectivity. Therefore, landiolol effectively reduces heart rate with only minimal negative effects on blood pressure and inotr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gangl, Clemens, Krychtiuk, Konstantin A, Schoenbauer, Robert, Speidl, Walter S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acute Optimization of Heart Rate in Atrial Fibrillation: Landiolol as a First Line Therapy Supplement Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190750/
https://www.ncbi.nlm.nih.gov/pubmed/35706896
http://dx.doi.org/10.1093/eurheartjsupp/suac026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190750/
https://www.ncbi.nlm.nih.gov/pubmed/35706896
http://dx.doi.org/10.1093/eurheartjsupp/suac026

Ejemplares similares